Oral mucosal disease: Pemphigus

British Journal of Oral and Maxillofacial Surgery

Volumn 46, Issue 4, 2008, Pages 272-277

  Scully, Crispian ^a   Mignogna, Michele ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Autoimmune; Immunosuppressants; Oral; Pemphigus; Skin; Vesiculobullous

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CAPTOPRIL; CEPHALOSPORIN; CILAZAPRIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DEFLAZACORT; DESMOCOLLIN; DESMOPLAKIN; DEXAMETHASONE; ENALAPRIL; FOSINOPRIL; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G4; LEVODOPA; METHYLPREDNISOLONE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PENICILLIN G; PERIPLAKIN; PROPRANOLOL; RAMIPRIL; RIFAMPICIN; TRIAMCINOLONE; UNINDEXED DRUG;

ARTICLE; AUTOIMMUNITY; CLINICAL FEATURE; DISEASE ASSOCIATION; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INDIAN; JEW; ORAL BIOPSY; ORAL MUCOSAL DISEASE; PEMPHIGUS; PLASMAPHERESIS;

AUTOANTIBODIES; DESMOGLEIN 3; GLUCOCORTICOIDS; HLA-DR4 ANTIGEN; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INDIA; JEWS; MEDITERRANEAN REGION; MOUTH DISEASES; PEMPHIGUS;

EID: 43049096059     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2007.07.205     Document Type: Article

References (65)

1. Bystryn J.C., and Rudolph J.L. Pemphigus. Lancet 366 (2005) 61-73
2. Black M., Mignogna M.D., and Scully C. Number II. Pemphigus vulgaris. Oral Dis 11 (2005) 119-130
3. Kaplan I., Hodak E., Ackerman L., Mimouni D., Anhalt G.J., and Calderon S. Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations. Oral Oncol 40 (2004) 553-562
4. Anon. Pemphigus: current concepts. Ann Intern Med 1980;92:396-405.
5. Tron F., Gilbert D., Mouquet H., et al. Genetic factors in pemphigus. J Autoimmun 24 (2005) 319-328
6. Pisanti S., Sharav Y., Kaufman E., and Posner L.N. Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion. Oral Surg Oral Med Oral Pathol 38 (1974) 382-387
7. Lombardi M.L., Mercuro O., Tecame G., et al. Molecular analysis of HLA DRB1 and DQB1 in Italian patients with pemphigus vulgaris. Tissue Antigens 47 (1996) 228-230
8. Mobini N., Padilla Jr. T., and Ahmed A.R. Long-term remission in selected patients with pemphigus vulgaris treated with cyclosporine. J Am Acad Dermatol 36 (1997) 264-266
9. Delgado J.C., Hameed A., Yunis J.J., et al. Pemphigus vulgaris autoantibody response is linked to HLA-DQB1*0503 in Pakistani patients. Hum Immunol 57 (1997) 110-119
10. Loiseau P., Lecleach L., Prost C., et al. HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus. J Autoimmun 15 (2000) 67-73
11. Tur E., and Brenner S. Diet and pemphigus. In pursuit of exogenous factors in pemphigus and fogo selvagem. Arch Dermatol 134 (1998) 1406-1410
12. Ruocco E., Aurilia A., and Ruocco V. Precautions and suggestions for pemphigus patients. Dermatology 203 (2001) 201-207
13. Ruocco V., Wolf R., Ruocco E., and Baroni A. Viruses in pemphigus: a casual or causal relationship?. Int J Dermatol 35 (1996) 782-784
14. Bezold G., Sander C.A., Flaig M.J., Peter R.U., and Messer G. Lack of detection of human herpesvirus (HHV)-8 DNA in lesional skin of German pemphigus vulgaris and pemphigus foliaceus patients. J Invest Dermatol 114 (2000) 739-741
15. Nishikawa T., Hashimoto T., Shimizu H., Ebihara T., and Amagai M. Pemphigus: from immunofluorescence to molecular biology. J Dermatol Sci 12 (1996) 1-9
16. Yancey K.B. The pathophysiology of autoimmune blistering diseases. J Clin Invest 115 (2005) 825-828
17. Anhalt G.J., and Diaz L.A. Prospects for autoimmune disease: research advances in pemphigus. JAMA 285 (2001) 652-654
18. Frusic-Zlotkin M., Pergamentz R., Michel B., et al. The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients. Ann N Y Acad Sci 1050 (2005) 371-379
19. Miyagawa S., Amagai M., Iida T., Yamamoto Y., Nishikawa T., and Shirai T. Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression. Br J Dermatol 141 (1999) 1084-1087
20. Harman K.E., Gratian M.J., Bhogal B.S., Challacombe S.J., and Black M.M. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype. Br J Dermatol 143 (2000) 343-348
21. Kricheli D., David M., Frusic-Zlotkin M., et al. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmogein 3 and 1 in pemphigus patients and their first degree relatives. Br J Dermatol 143 (2000) 337-342
22. Scully C., Paes De Almeida O., Porter S.R., and Gilkes J.J. Pemphigus vulgaris: the manifestations and long-term management of 55 patients with oral lesions. Br J Dermatol 140 (1999) 84-89
23. Scully C., and Porter S.R. The clinical spectrum of desquamative gingivitis. Semin Cutan Med Surg 16 (1997) 308-313
24. Davenport S., Chen S.Y., and Miller A.S. Pemphigus vulgaris: clinicopathologic review of 33 cases in the oral cavity. Int J Periodontics Restor Dent 21 (2001) 85-90
25. Femiano F., Gombos F., Nunziata M., Esposito V., and Scully C. Pemphigus mimicking aphthous stomatitis. J Oral Pathol Med 34 (2005) 508-510
26. Shklar G., Frim S., and Flynn E. Gingival lesions of pemphigus. J Periodontol 49 (1978) 428-435
27. Mignogna M.D., Pannone G., Lo Muzio L., Staibano S., and Bucci E. Catenin dislocation in oral pemphigus vulgaris. J Oral Pathol Med 30 (2001) 268-274
28. Mignogna M.D., Lo Muzio L., Galloro G., Satriano R.A., Ruocco V., and Bucci E. Oral pemphigus: clinical significance of esophageal involvement: report of eight cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84 (1997) 179-184
29. Sirois D.A., Fatahzadeh M., Roth R., and Ettlin D. Diagnostic patterns and delays in pemphigus vulgaris: experience with 99 patients. Arch Dermatol 136 (2000) 1569-1570
30. Uzun S., and Durdu M. The specificity and sensitivity of Nikolskiy sign in the diagnosis of pemphigus. J Am Acad Dermatol 54 (2006) 411-415
31. Harman K.E., Gratian M.J., Seed P.T., Bhogal B.S., Challacombe S.J., and Black M.M. Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3. Clin Exp Dermatol 25 (2000) 236-240
32. Galloro G., Mignogna M., de Werra C., et al. The role of upper endoscopy in identifying oesophageal involvement in patients with oral pemphigus vulgaris. Dig Liver Dis 37 (2005) 195-199
33. Herbst A., and Bystryn J.C. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol 42 (2000) 422-427
34. Mignogna M.D., Lo Muzio L., Mignogna R.E., Carbone R., Ruoppo E., and Bucci E. Oral pemphigus: long term behaviour and clinical response to treatment with deflazacort in sixteen cases. J Oral Pathol Med 29 (2000) 145-152
35. Werth V.P. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids. Arch Dermatol 132 (1996) 1435-1439
36. Mignogna M.D., Lo Muzio L., Ruoppo E., Fedele S., Lo Russo L., and Bucci E. High-dose intravenous 'pulse' methylprednisone in the treatment of severe oropharyngeal pemphigus: a pilot study. J Oral Pathol Med 31 (2002) 339-344
37. Rosenberg F.R., Sanders S., and Nelson C.T. Pemphigus: a 20-year review of 107 patients treated with corticosteroids. Arch Dermatol 112 (1976) 962-970
38. Cheng S.W., Kobayashi M., Kinoshita-Kuroda K., Tanikawa A., Amagai M., and Nishikawa T. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3. Br J Dermatol 147 (2002) 261-265
39. Turner M.S., Sutton D., and Sauder D.N. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris. J Am Acad Dermatol 43 (2000) 1058-1064
40. Ruocco V. Plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris: a novelty or a reappraisal?. Arch Dermatol 124 (1988) 1716-1718
41. Heaphy M.R., Albrecht J., and Werth V.P. Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris. Arch Dermatol 141 (2005) 699-702
42. Roenigk Jr. H.H., and Deodhar S. Pemphigus treatment with azathioprine. Clinical and immunologic correlation. Arch Dermatol 107 (1973) 353-357
43. Shah N., Green A.R., Elgart G.W., and Kerdel F. The use of chlorambucil with prednisone in the treatment of pemphigus. J Am Acad Dermatol 42 (2000) 85-88 1570
44. Pasricha J.S., Thanzama J., and Khan U.K. Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus. Br J Dermatol 119 (1988) 73-77
45. Salomon D., and Saurat J.H. Oral gold therapy (Auranofin) in pemphigus vulgaris. Dermatology 172 (1986) 310-314
46. Morita H., Morisaki S., and Kitano Y. Clinical trial of prostaglandin E2 on the oral lesions of pemphigus vulgaris. Br J Dermatol 132 (1995) 165-166
47. Gaspar Z.S., Walkden V., and Wojnarowska F. Minocycline is a useful adjuvant therapy for pemphigus. Australas J Dermatol 37 (1996) 93-95
48. Rose E., Wever S., Zilliken D., Linse R., Haustein U.F., and Brocker E.B. Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study. J Dtsch Dermatol Ges 3 (2005) 200-206
49. Hayag M.V., Cohen J.A., and Kerdel F.A. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris. J Am Acad Dermatol 43 (2000) 1065-1069
50. Ioannides D., Chrysomallis F., and Bystryn J.C. Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus. Arch Dermatol 136 (2000) 868-872
51. Smith T.J., and Bystryn J.C. Methotrexate as an adjuvant treatment for pemphigus vulgaris. Arch Dermatol 135 (1999) 1275-1276
52. Carson P.J., Hameed A., and Ahmed A.R. Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol 34 (1996) 645-652
53. Akerman L., Mimouni D., and David M. Intravenous immunoglobulin for treatment of pemphigus. Clin Rev Allergy Immunol 29 (2005) 289-294
54. Bredlich R.O., Grundmann-Kollmann M., Behrens S., Kerscher M., and Peter R.U. Mycophenolate mofetil monotherapy for pemphigus vulgaris. Br J Dermatol 141 (1999) 934
55. Powell A.M., Albert S., Al Fares S., et al. An evaluation of the usefulness of mycophenolate mofetil in pemphigus. Br J Dermatol 149 (2003) 138-145
56. Wu S.J., Tanphaichitr A., and Ly M. Recent advances in dermatology. Clin Podiatr Med Surg 19 (2002) 65-78
57. Nguyen V.T., Arredondo J., Chernyavsky A.I., Pittelkow M.R., Kitajima Y., and Grando S.A. Pemphigus vulgaris acantholysis ameliorated by cholinergic agonists. Arch Dermatol 140 (2004) 327-334
58. Frost N., Messer G., Fierlbeck G., Risler T., and Lytton S.D. Treatment of pemphigus vulgaris with protein a immunoadsorption: case report of long-term history showing favorable outcome. Ann N Y Acad Sci 1051 (2005) 591-596
59. Eming R., Rech J., Barth S., et al. Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption. Dermatology 212 (2006) 177-187
60. Arin M.J., Engert A., Krieg T., and Hunzelmann N. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus. Br J Dermatol 153 (2005) 620-625
61. Schmidt E., Herzog S., Brocker E.B., Zillikens D., and Goebeler M. Long-standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab. Br J Dermatol 153 (2005) 449-451
62. Pardo J., Mercader P., Mahiques L., Sanchez-Carazo J.L., Oliver V., and Fortea J.M. Infliximab in the management of severe pemphigus vulgaris. Br J Dermatol 153 (2005) 222-223
63. Dobrev H., Popova L., and Vlashev D. Proteinase inhibitors and pemphigus vulgaris. an in vitro and in vivo study. Arch Dermatol Res 288 (1996) 648-655
64. Proby C.M., Ota T., Suzuki H., et al. Development of chimeric molecules for recognition and targeting of antigen-specific B cells in pemphigus vulgaris. Br J Dermatol 142 (2000) 321-330
65. Hertl M., and Riechers R. Analysis of the T cells that are potentially involved in autoantibody production in pemphigus vulgaris. J Dermatol 26 (1999) 748-752